Because labeling is global and requires localization, pharma companies gain even more benefit from content reuse.
Learn how a structured content ecosystem results in better content for pharma companies and the importance of XML, CDISC, and content standards.
There is no such thing as a perfect structure because it is going to change over time. With new products and services should come new content types. And new content types often require new structures.
In this webinar, we present an improved solution for creating, storing, and managing critical CDS information in one location.
Most people would agree that the Core Data Sheet (CDS) contains some of the most critical information for pharma companies. At the same time, crucial information is also created from the CDS. Knowing how important the CDS is, why are most pharma companies using a Word document to create, store,
The first thing to decide about special statements is how you will use each category. What type of information goes into a note? A caution? A warning? What really is the difference between a caution and a warning? Most companies that I work with have not defined caution versus warning,
There are many reasons why a component structured content management (SCM) system is superior to using a Microsoft Word document for managing your Company Core Data Sheet (CDS or CCDS). We touched upon some of the reasons in our previous blog post, The CDS is Dead! Long Live the CDS!
The Company Core Data Sheet (CDS or CCDS) is one of the most important documents a pharmaceutical company creates. The CDS is a working document that contains information about the pharmaceutical product. It includes information from multiple sources, such as clinical trial data systems, clinical report documents, CMC data systems,
After decades (literally) of talking about silos, calmly and not so calmly explaining to people why they are problematic, and advocating for their demise, I have come to the (obvious) conclusion that we are not going to eliminate them any time soon. If you already figured this out, you are
“We cannot change the authoring experience.” This, more than anything else, is the message we used to be told (and still hear often) when we suggest a component-based structured authoring environment for medical writers at pharmaceutical companies. The authoring experience using Microsoft Word reigns supreme. Any changes to this interface